Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Amneal Pharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (358)

Date

2022 (49)
2021 (17)
2020 (22)
2019 (109)
2018 (78)
2017 (81)
2016 (1)
2015 (1)

Results for "[search-keyword]"

Search

Sponsor content

358 result(s) found, displaying 81 to 90

RISEDRONATE AN risedronate sodium 35mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
METOPROLOL AN metoprolol tartrate 100 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
METOPROLOL AN metoprolol tartrate 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
FAMCICLOVIR AN famciclovir 500 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
SERTRALINE AN sertraline (as hydrochloride) 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
CITALOPRAM AN citalopram hydrobromide 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
METFORMIN AN metformin hydrochloride 1000 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
METFORMIN AN metformin hydrochloride 500 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2020

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
RANITIDINE AN ranitidine (as hydrochloride) 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 November 2019

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
PHARMACY CHOICE OMEPRAZOLE HEARTBURN RELIEF 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 July 2019

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd

Pages

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.